ReviewThe Lancet regional health. Europe2024

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries.

Vincent D de Jager et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.